Objectif
A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for:
1. continues expressing of biologicals to fulfill the expectation to “personalized medicine” and 2. proliferation of cells to support therapeutic applications and 3. proliferation of stem cells to prepare manufacturing of real “human spare
parts”. Advanced process control inside tailor made and cell harboring scaffolds integrated in a High-Efficient-Single-Use-Bioreactor simulating mammalian tissue conditions will fulfill this requirements
Champ scientifique
Appel à propositions
FP7-HEALTH-2013-INNOVATION-2
Voir d’autres projets de cet appel
Régime de financement
CP-FP - Small or medium-scale focused research projectCoordinateur
100 44 Stockholm
Suède